Evidence map›Paper›PMID 19137272›Full record

ReviewDer Internist2009

[Infections in hematology and oncology. Epidemiology--diagnosis--risk-adapted antimicrobial treatment--prevention].

G Maschmeyer, M Sandherr

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Der Internist, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

G MaschmeyerKlinik für Hämatologie und Onkologie, Klinikum Ernst von Bergmann, Charlottenstrasse 72, 14467, Potsdam, Deutschland. gmaschmeyer@klinikumevb.de
M Sandherr

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections are the predominant complications in patients with hematological and oncological diseases undergoing chemotherapy or stem cell transplantation. The spectrum of causative pathogens depends on the suppression of granulopoiesis, T-cell immunity or humoral deficiency, so that recommendations for prevention, diagnostic approach and antimicrobial treatment should be specified for each cohort of patients. Following these rules, outcomes of prophylaxis and treatment today are favorable, although for some patient populations, the intensity of antimicrobial intervention has been reduced. Recommendations for prevention, including vaccination, should be known and followed for hospitalized as well as for out-patients.

Indexed as

Antineoplastic AgentsBacterial InfectionsHematologyHumansMedical OncologyMycosesRisk AssessmentStem Cell TransplantationAntineoplastic Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.